Cargando…

Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome

Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a novel chemiluminescence assay (CIA) in detection of IgG/IgM/IgA anti-cardiolipin (aCL) and IgG/IgM/IgA anti-β2 glyco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shulan, Wu, Ziyan, Li, Ping, Bai, Yina, Zhang, Fengchun, Li, Yongzhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	Diagnostic Accuracy Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652825/ https://www.ncbi.nlm.nih.gov/pubmed/26579816 http://dx.doi.org/10.1097/MD.0000000000002059

Ejemplares similares

Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome
por: Zhang, Shulan, et al.
Publicado: (2016)

Computed Tomography-Derived Fractional Flow Reserve in the Detection of Lesion-Specific Ischemia: An Integrated Analysis of 3 Pivotal Trials
por: Xu, Rende, et al.
Publicado: (2015)

Increasing discrepancy of MR imaging and CSF study in patients with leptomeningeal seeding from lung adenocarcinoma after targeted therapy using a tyrosine kinase inhibitor
por: Seong, Minjung, et al.
Publicado: (2023)

Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998)

Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019)

The diagnostic accuracy of the GenoType® Mtbdrsl assay for the detection of resistance to second-line anti-tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2014)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
por: Melayah, Sarra, et al.
Publicado: (2022)

The outstanding diagnostic value of DKI in multimodal magnetic resonance imaging for benign and malignant breast tumors: A diagnostic accuracy study
por: Gao, Yufei, et al.
Publicado: (2023)

Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19
por: Garcia-Arellano, Gisela, et al.
Publicado: (2023)

Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease
por: Zhang, Shulan, et al.
Publicado: (2015)

A nomogram for preoperative differentiation of tumor deposits from lymph node metastasis in rectal cancer: A retrospective study
por: Jin, Yumei, et al.
Publicado: (2023)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients
por: Trahtemberg, Uriel, et al.
Publicado: (2021)

Clinicopathological features and correlation analysis of male breast cancer
por: Xi, Lei, et al.
Publicado: (2023)

Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes
por: Wu, Li, et al.
Publicado: (2022)

Advances in the Research on Anticardiolipin Antibody
por: Wang, Dan, et al.
Publicado: (2019)

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks
por: Haghighipour, Somayeh, et al.
Publicado: (2023)

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease
por: Zhang, Shulan, et al.
Publicado: (2018)

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
Publicado: (1994)

Development of a novel magnetic particle-based agglutination immunoassay for anticardiolipin antibody detection in syphilis
por: Shukla, Mayur R, et al.
Publicado: (2020)

Serological chemiluminescence immunoassay for the diagnosis of SARS‐CoV‐2 infection
por: Lijia, Shao, et al.
Publicado: (2020)

Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome
por: Xi, Fangfang, et al.
Publicado: (2020)

The Clinical Performance of a New Chemiluminescent Immunoassay in Measuring Anti-β2 Glycoprotein 1 and Anti-Cardiolipin Antibodies
por: Zhou, Jiansuo, et al.
Publicado: (2018)

Chemiluminescence Immunoassay to Detect Anti‐HTLV‐I Antibodies
por: Kamihira, Shimeru, et al.
Publicado: (1993)

Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis
por: Li, Liubing, et al.
Publicado: (2016)

The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome
por: Brusch, Anna
Publicado: (2016)

Association of anticardiolipin antibodies with epilepsy in children
por: Shiva, Shadi, et al.
Publicado: (2023)

Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody
por: Yang, Shuo, et al.
Publicado: (2019)

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
por: Zhang, Yan, et al.
Publicado: (2020)

Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis
por: Mo, Xiaohui, et al.
Publicado: (2010)

Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis
por: Ishii, Toshiaki, et al.
Publicado: (2021)

The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies
por: Hou, Xiuzhu, et al.
Publicado: (2020)

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
por: McDonnell, Thomas, et al.
Publicado: (2018)

Highly Specific Chemiluminescence Immunoassay for the Determination of Chloramphenicol in Cosmetics
por: Li, Qiyan, et al.
Publicado: (2019)

Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID‐19 cohorts by chemiluminescent immunoassays
por: Dou, Xiaowen, et al.
Publicado: (2022)

Establishing a reference interval for serum anti-dsDNA antibody: A large Chinese Han population-based multi-center study
por: Deng, Chuiwen, et al.
Publicado: (2017)

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis
por: Wang, Le, et al.
Publicado: (2021)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Prevalence of Anticardiolipin Antibodies in Pregnancies with History of Repeated Miscarriages
por: Spegiorin, Ligia Cosentino Junqueira Franco, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fbkg1fvji1k98gej9dmukgipjv